Literature DB >> 14682078

FDA approves memantine drug for treating AD.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682078

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


× No keyword cloud information.
  5 in total

Review 1.  The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.

Authors:  Jaclyn Cappell; Nathan Herrmann; Stephen Cornish; Krista L Lanctôt
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

2.  Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficits.

Authors:  Peter D Cole; Veena Vijayanathan; Nafeeza F Ali; Mark E Wagshul; Eric J Tanenbaum; Jeremy Price; Vidhi Dalal; Maria E Gulinello
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

Review 3.  A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.

Authors:  Jacob S Buckley; Shelley R Salpeter
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

4.  Memantine for dementia.

Authors:  Rupert McShane; Maggie J Westby; Emmert Roberts; Neda Minakaran; Lon Schneider; Lucy E Farrimond; Nicola Maayan; Jennifer Ware; Jean Debarros
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20

Review 5.  History and progress of hypotheses and clinical trials for Alzheimer's disease.

Authors:  Pei-Pei Liu; Yi Xie; Xiao-Yan Meng; Jian-Sheng Kang
Journal:  Signal Transduct Target Ther       Date:  2019-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.